Summit Therapeutics, Inc. Logo

Summit Therapeutics, Inc.

Senior Manager, SEC Reporting & Technical Accounting

Posted 13 Days Ago
Be an Early Applicant
In-Office
Palo Alto, CA, USA
148K-170K Annually
Senior level
In-Office
Palo Alto, CA, USA
148K-170K Annually
Senior level
Lead preparation and filing of SEC reports (10-K/10-Q), document technical accounting, manage SOX/ICFR program, coordinate audits, research accounting standards, handle complex transactions including equity and collaboration accounting, maintain stock compensation accounting, and improve accounting policies and disclosures.
The summary above was generated by AI

About Summit:

Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence.

Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including:

Non-small Cell Lung Cancer (NSCLC)

  • HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI.

  • HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC.

  • HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC.

Colorectal Cancer (CRC)

  • HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy.

Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland.

Overview of Role:

The Senior Manager, SEC Reporting and Technical Accounting will be responsible for the preparation and filing of SEC reporting and disclosures, documenting technical accounting matters and ensuring compliance with U.S. GAAP and SEC regulations.  This role will also lead the Company’s  Sabarnes-Oxley (SOX) compliance program, and be involved in complex accounting transactions including accruals, collaboration accounting, and equity accounting.

Role and Responsibilities:

  • Participate in the preparation of all external financial reporting, including Forms 10-K/10-Q, earnings releases, proxy statement, and other required SEC filings to ensure accurate and timely reporting in accordance with U.S. GAAP.
  • In conjunction with the Director of SEC Reporting and Technical Accounting, manage the Company's external financial reporting process, including the preparation of financial statements, footnotes, Management's Discussion and Analysis (MD&A), and other required disclosures in accordance with U.S. GAAP and SEC reporting requirements.
  • Preparation of the Statement of Cash Flows, Statement of Shareholder’s equity, Earnings per Share workbooks and other financial disclosure requirements with such filings
  • Coordinate the information gathering process across the organization and interact with the Company’s external auditors
  • Review XBRL interactive data files for all Form 10-Q and 10-K filings in accordance with the SEC filing requirements
  • Research, document memos, record, and communicate technical accounting matters as they arise and journal entries for complex accounting transactions
  • Analyze and interpret new accounting standards and SEC regulations, research and provide appropriate accounting guidance related to various business transactions
  • Research new disclosures and FASB accounting standards updates and work with external auditors on appropriate disclosure requirements
  • Develop, create and/or modify the company’s financial accounting policies and procedures to ensure that the policies and procedures are in accordance with U.S. GAAP
  • Stock compensation administration and accounting for share-based compensation awards, including stock options, RSU’s, ESPP by performing the valuation of compensation granted, calculation of monthly expense, and forecasting future impact to the Company and all related stock compensation disclosure requirements
  • Lead and manage the Company's SOX compliance program, including planning, execution, and ongoing monitoring of internal controls over financial reporting (ICFR).
  • Complete special projects as assigned
  • All other duties as assigned

Experience, Education and Specialized Knowledge and Skills:

  • Minimum bachelor’s degree in accounting. CPA required
  • Minimum 8+ years of work experience, including a minimum of 3 years of Big 4 public accounting experience
  • Strong understanding of US GAAP, SEC reporting requirements, and Sarbanes-Oxley compliance requirements
  • Results-oriented, strong organizational skills, and time management skills with ability to multi-task
  • Experience with NetSuite, Shareworks, and Workiva preferred
  • Prior work experience at Bio tech company is preferred
  • A team player willing to step in and help with other areas of accounting
  • Excellent analytical, interpersonal, verbal, and written communication skills
  • Superb analytical, strategic, and critical thinking skills, with impeccable attention to detail, and strong prioritization and problem-solving skills
  • Demonstrated ability to operate in a fast-paced environment

This is the pay for this position

Pay Transparency
$148,000$170,000 USD

Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation.

Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summit’s Talent Acquisition team at [email protected] to obtain prior written authorization before referring any candidates to Summit.

Summit Therapeutics Inc. is an Equal Opportunity Employer and takes pride in creating and maintaining diverse environment. We do not discriminate in recruitment, hiring, training or promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status.

HQ

Summit Therapeutics, Inc. Menlo Park, California, USA Office

Menlo Park, CA, United States

Summit Therapeutics, Inc. Palo Alto, California, USA Office

1000 Page Mill Rd, Palo Alto, California, United States, 94304 1019

Similar Jobs

7 Minutes Ago
Hybrid
San Francisco, CA, USA
259K-351K Annually
Junior
259K-351K Annually
Junior
Cloud • Healthtech • Social Impact • Software • Biotech
Build end-to-end LLM-powered AI agents that automate scientific workflows, collaborate with customers to gather feedback and onboard teams, engineer across backend and frontend stacks, improve agent platform tooling and infrastructure, and shape technical direction for AI within the product.
Top Skills: Ai AgentsLarge Language Models (Llms)PythonReact
9 Minutes Ago
In-Office or Remote
San Mateo, CA, USA
165K-350K Annually
Senior level
165K-350K Annually
Senior level
Artificial Intelligence • Legal Tech
Build and maintain the Microsoft Word add-in that connects GC AI's models to Word, focusing on latency, reliability, real-time document manipulation (tracked changes, comments), editor UX, and shipping enterprise features like clause libraries, playbook reviews, and contextual drafting.
Top Skills: Microsoft Office Add-InsReactTypescriptVs Code Extensions
20 Minutes Ago
Hybrid
San Jose, CA, USA
203K-254K Annually
Expert/Leader
203K-254K Annually
Expert/Leader
Aerospace • Artificial Intelligence • Cloud • Machine Learning • Software • Cybersecurity • Defense
Lead and execute the quality strategy across supplier quality, quality engineering, inspection, documentation, calibration, and audits. Manage a multi-disciplinary team, drive root-cause investigations and corrective actions, maintain ISO-9001/AS9100 systems, and partner with Engineering, Manufacturing, and Supply Chain to embed quality across the product lifecycle.
Top Skills: As9100Calibration SystemsIso-9001Q-NoteSap ErpSiemens TeamcenterStatistical Process Control (Spc)

What you need to know about the San Francisco Tech Scene

San Francisco and the surrounding Bay Area attracts more startup funding than any other region in the world. Home to Stanford University and UC Berkeley, leading VC firms and several of the world’s most valuable companies, the Bay Area is the place to go for anyone looking to make it big in the tech industry. That said, San Francisco has a lot to offer beyond technology thanks to a thriving art and music scene, excellent food and a short drive to several of the country’s most beautiful recreational areas.

Key Facts About San Francisco Tech

  • Number of Tech Workers: 365,500; 13.9% of overall workforce (2024 CompTIA survey)
  • Major Tech Employers: Google, Apple, Salesforce, Meta
  • Key Industries: Artificial intelligence, cloud computing, fintech, consumer technology, software
  • Funding Landscape: $50.5 billion in venture capital funding in 2024 (Pitchbook)
  • Notable Investors: Sequoia Capital, Andreessen Horowitz, Bessemer Venture Partners, Greylock Partners, Khosla Ventures, Kleiner Perkins
  • Research Centers and Universities: Stanford University; University of California, Berkeley; University of San Francisco; Santa Clara University; Ames Research Center; Center for AI Safety; California Institute for Regenerative Medicine

Sign up now Access later

Create Free Account

Please log in or sign up to report this job.

Create Free Account